Biocon Market Cap

Biocon has a market cap or net worth of 603.65 billion as of January 23, 2026. Its market cap has increased by 36.60% in one year.

Market Cap

603.65B

Enterprise Value

770.49B

Revenue

164.76B

Ranking

n/a

PE Ratio

124.34

Stock Price

372.65

Market Cap Chart

Since April 7, 2004, Biocon's market cap has increased from 45.41B to 603.65B, an increase of 1,229.25%. That is a compound annual growth rate of 12.60%.

Market Cap History

Date	Market Cap	% Change
Jan 22, 2026	603.65B	14.84%
Dec 31, 2025	525.64B	20.22%
Dec 31, 2024	437.25B	46.69%
Dec 29, 2023	298.08B	-4.59%
Dec 30, 2022	312.41B	-27.97%
Dec 31, 2021	433.73B	-21.37%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Aarti Drugs	34.24B
Hester Biosciences	12.05B
Titan Biotech	7.98B
Zenotech Laboratories	2.80B
Genesis IBRC India	970.19M
Bharat Immunologicals & Biologicals Corporation	786.31M
Transgene Biotek	186.39M
Hindustan Bio Sciences	63.25M

Market Cap Rankings